New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion

September 14, 2016 | A group of scientists and entrepreneurs believe that computers and various biotechnologies can determine how proteins, instead of folding into a permanent shape, shimmy from one shape to another, and how those back-and-forth states can be exploited to treat disease. They've formed a startup called Relay Therapeutics to test the concept and make drugs for cancer and other diseases. Xconomy